Change of Expression

For this article, Steve Bunk interviewed Rudolf Aebersold, cofounder, Institute for Systems Biology, Seattle. Data from the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age. S.P. Gygi, Y. Rochon, B.R. Franza, R. Aebersold, "Correlation between protein and mRNA abundance in yeast," Molecular and Cellular Biology, 19:1720-30, March, 1999. (Cited in 114 papers) At virtually all levels of life sciences, fro

Written bySteve Bunk
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

This paper, produced when Aebersold was still at the University of Washington, demonstrated how science can build on the achievements of genomics to reach proteins, the next level of systems analysis. It did so, in part, by proving that messenger RNA transcript levels are poor predictors of protein expression levels in yeast. "The main point is, if you want to know what the proteome consists of, you can't just measure mRNA levels," Aebersold summarizes.

Using two-dimensional gel electrophoresis and mass spectrometry, his team analyzed 156 protein spots from the yeast Saccaromyces cerevisiae. These spots represented the products of 128 genes, narrowed to 106 after researchers excluded some for a lack of corresponding mRNA expression data and other factors. Correlations between mRNA levels and protein expression were poor in most genes, for which the message level was below 10 copies per cell. Some genes with comparable mRNA levels had a 30-fold ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies